Profil
Christopher Naughton has been a Director of Glycotex, Inc. since 1999, Chairman since September 2005 and President and Chief Executive Officer since October 2005.
He was President of Glycotex, Inc. from May 1999 to September 2005.
He has been a Director, President and Chief Executive Officer of Marshall Edwards, Inc. since 2000.
He has been Managing Director of Novogen since March 1997.
He received an undergraduate degree from Australian National University and the University of New South Wales.
Anciens postes connus de Christopher Naughton
| Sociétés | Poste | Fin |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | President | 01/12/2009 |
| MEI PHARMA, INC. | President | 01/12/2009 |
Glycotex, Inc.
 Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Président | - |
Formation de Christopher Naughton
| The University of New South Wales | Graduate Degree |
| Australian National University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |